Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Blood (2023) 142 (Supplement 1): 7016.

https://doi.org/10.1182/blood-2023-177866

Published: 2023

Journal Articles

Severe Cytopenia after CD19 CAR T-Cell Therapy: A Retrospective Study from the EBMT Transplant Complications Working Party

Blood (2022) 140 (Supplement 1): 4664–4667.

https://doi.org/10.1182/blood-2022-168614

Published: 2022

Journal Articles

Organ Complications after CD19 CAR T-Cell Therapy for Large B Cell Lymphoma. a Retrospective Study from the EBMT Transplant Complications and Lymphoma Working Partys

Blood (2022) 140 (Supplement 1): 10413–10415.

https://doi.org/10.1182/blood-2022-169037

Published: 2022

Journal Articles

Artificial Intelligence Methods to Estimate Overall Mortality and Non-Relapse Mortality Following Allogeneic Hematopoietic Cell Transplantation in the Modern Era: An EBMT Transplant Complications Working Party Study

Blood (2022) 140 (Supplement 1): 7734–7737.

https://doi.org/10.1182/blood-2022-168601

Published: 2022

Journal Articles

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

Jia Chen, Yiyang Ding, Xi Zhang, Erlie Jiang, Lin Liu, He Huang, Jiong Hu, Jishi Wang, Yanming Zhang, Myriam Labopin, Irma Khvedelidze, Emmanuelle Polge, Arnon Nagler, Mohamad Mohty, Depei Wu, Norbert Claude Gorin, Sr.

Blood (2022) 140 (Supplement 1): 12952–12953.

https://doi.org/10.1182/blood-2022-165709

Published: 2022

Journal Articles

Comparable Outcomes Following Non-First-Degree and First-Degree Related Donor Haploidentical Hematopoietic Cell Transplantation for Acute Leukemia Patients in Complete Remission: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Yishan Ye, Myriam Labopin, Jia Chen, Zafer Gulbas, Xi Zhang, Yener Koc, Didier Blaise, Fabio Ciceri, Emmanuelle Polge, Houhou Mohamad, Lin Li, Yi Luo, Depei Wu, He Huang, Mohamad Mohty, Norbert Claude Gorin, Sr.

Blood (2022) 140 (Supplement 1): 10603–10605.

https://doi.org/10.1182/blood-2022-158482

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia with Hyperdiploid Complex Karyotype: A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Arnold Ganser, Gerard Socie, Tobias Gedde-Dahl, Edouard Forcade, Jürgen Finke, Sr., Yves Chalandon, Claude-Eric Bulabois, Ibrahim Yakoub-Agha, Mahmoud Aljurf, Nicolaus Kröger, Igor Wolfgang Blau, Arnon Nagler, Jordi Esteve, Mohamad Mohty

Blood (2021) 138 (Supplement 1): 3952.

https://doi.org/10.1182/blood-2021-150306

Published: 2021

Journal Articles

From Ex-Vivo T-Cell Depletion to Post-Transplant Cyclophosphamide: Improved GvHD-Free & Relapse-Free Survival but Comparable Chronic GvHD Incidence in Haploidentical Transplantation. A 15 Years EBMT Registry Analysis on Behalf of the TCWP-EBMT

Maria Teresa Lupo-Stanghellini, MD, Christophe Peczynski, Hildegard T. Greinix, MD, Emmanuelle Polge, Mohamad Mohty, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Silvia Montoto, MD, Nicolaus Kröger, MD, Zinaida Peric, MD PhD, Olaf Penack, MD, Rafael F Duarte, MDPhDFRCP, Grzegorz W Basak, MD PhD Professor

Blood (2019) 134 (Supplement_1): 876.

https://doi.org/10.1182/blood-2019-129105

Published: 2019

Journal Articles

The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 43.

https://doi.org/10.1182/blood-2019-123310

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Blood (2017) 130 (Supplement 1): 595.

https://doi.org/10.1182/blood.V130.Suppl_1.595.595

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Marina Diaz Beya, MD, Myriam Labopin, MD PhD, Johan Maertens, Alijurf Mahmoud, MD, Alois Gratwohl, MD, Dietrich W Beelen, MD PhD, Harry C. Schouten, MD, Gérard Socié, MDPhD, Antonius VMB Schattenberg, MD PhD, Rainer Schwerdtfeger, MD, Liisa Volin, Mauricette Michallet, MD PhD, Emmanuelle Polge, Mohamad Mohty, MD PhD, Jordi Esteve, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 596.

https://doi.org/10.1182/blood.V130.Suppl_1.596.596

Published: 2017

Journal Articles

Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, MD, Emmanuelle Polge, Taiga Nishihori, MD, Ali Bazarbachi, MD PhD, Jürgen Finke, MD, Michael Stadler, MD PhD, Gerhard Ehninger, Bruno Lioure, MD, Nicolaas Schaap, Boris V Afanasyev, MD PhD Professor, Moshe Yeshurun, Cecilia Isaksson, Johan Maertens, Yves Chalandon, MD PhD, Christoph Schmid, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2017) 130 (Supplement 1): 273.

https://doi.org/10.1182/blood.V130.Suppl_1.273.273

Published: 2017

Journal Articles

The Measurable Residual Disease Status of Acute Myeloid Leukemia in First Complete Remission at Allogeneic Hematopoietic Cell Transplantation Interacts with Conditioning Intensity to Predict Outcome

Maria Helena H. Gilleece, MD FRCPath, MB, BSc, FRCP, Myriam Labopin, MD PhD, Ibrahim Yakoub-Agha, Liisa Volin, Gerard Socie, MD PhD, Per Ljungman, Anne Huynh, MD, Eric Deconinck, MD PhD, Depei Wu, MD, Jean-Henri Bourhis, Mohamad Mohty, MD PhD, Jean-Yves Cahn, Emmanuelle Polge, Audrey Mailhol, MSc, Bipin N. Savani, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 522.

https://doi.org/10.1182/blood.V130.Suppl_1.522.522

Published: 2017

Journal Articles

The Disease Risk Index Is a Robust Tool for Allogeneic Hematopoietic Stem Cell Transplantation Risk Stratification: An Independent Validation Study on a Large Cohort of the European Society for Blood and Marrow Transplantation (EBMT)

Roni Shouval, MD, Joshua Fein, Myriam Labopin, Nicolaus Kroger, MD PhD, Rafael F. Duarte, MD PhD, Peter Bader, MD, Chiara Bonini, MD, Peter Dreger, MD, Carlo DuFour, MD, Andrew Gennery, MD, Jurgen Kuball, MD PhD, Francesco Lanza, MD, Silvia Montoto, MD, Emmanuelle Polge, John A Snowden, Jan Styczynski, MD PhD, Anna Sureda, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler

Blood (2016) 128 (22): 988.

https://doi.org/10.1182/blood.V128.22.988.988

Published: 2016

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia (AML) with Complex Karyotypes (CK): A Retrospective Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) and MD Anderson Cancer Center (MDACC)

Stefan O. Ciurea, MD, Myriam Labopin, MD, Emmanuelle Polge, Piyanuch Kongtim, MD, Gabriela Rondon, MD, Gerard Socie, MD PhD, Liisa Volin, MD PhD, Jakob R Passweg, MD, Patrice Chevallier, MD PhD, Dietrich W. Beelen, Prof. Dr. MD, Stéphane Vigouroux, MD, Didier Blaise, MD PhD, Jan J. Cornelissen, MD PhD, Nathalie Fegueux, MD, Mohamad Mohty, MD PhD, Bipin N. Savani, MD, Richard E. Champlin, MD, Arnon Nagler

Blood (2016) 128 (22): 3479.

https://doi.org/10.1182/blood.V128.22.3479.3479

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT

Blood (2015) 126 (23): 63.

https://doi.org/10.1182/blood.V126.23.63.63

Published: 2015

Journal Articles

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Julia Pingel, PhD, Camila J. Hernandez Frederick, PhD, Tao Wang, PhD, Emmanuelle Polge, Michael D Haagenson, MS, Stephanie J. Lee, MD MPH, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc, Stephen R. Spellman, MBS, Alexander H. Schmidt, MD PhD, Jon J. van Rood, MD PhD

Blood (2015) 126 (23): 3226.

https://doi.org/10.1182/blood.V126.23.3226.3226

Published: 2015

Journal Articles

Pomalidomide, Cyclophosphamide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Retrospective Single Center Experience

Laurent Garderet, MD, Emmanuelle Polge, mor Seny Gueye, Chaima Kellil, Jeanny Guelongo Okouango Ova, Eric Beohou, Myriam Labopin, MD, Mohamad Mohty, MD PhD

Blood (2015) 126 (23): 1858.

https://doi.org/10.1182/blood.V126.23.1858.1858

Published: 2015

Journal Articles

Upfront Autologous Stem Cell Transplantation for Newly Diagnosed Elderly Multiple Myeloma (MM) Patients: A Prospective Multicenter Study

Laurent Garderet, MD, Cyrille Touzeau, MD, Anne-Marie Stoppa, MD, Denis Caillot, Lionel Karlin, Philippe Moreau, MD PhD, Jean Fontan, Myriam Labopin, MD, Emmanuelle Polge, mor Seny Gueye, Eric Beohou, Souhila Ikhlef, Zora Marjanovic, Didier Blaise, MD PhD, Mohamad Mohty, MD

Blood (2015) 126 (23): 1989.

https://doi.org/10.1182/blood.V126.23.1989.1989

Published: 2015

Journal Articles

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation

Blood (2015) 126 (17): 2062–2069.

https://doi.org/10.1182/blood-2015-06-651562

Published: 2015

Includes: Supplemental data

NARROW

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Severe Cytopenia after CD19 CAR T-Cell Therapy: A Retrospective Study from the EBMT Transplant Complications Working Party

Organ Complications after CD19 CAR T-Cell Therapy for Large B Cell Lymphoma. a Retrospective Study from the EBMT Transplant Complications and Lymphoma Working Partys

Artificial Intelligence Methods to Estimate Overall Mortality and Non-Relapse Mortality Following Allogeneic Hematopoietic Cell Transplantation in the Modern Era: An EBMT Transplant Complications Working Party Study

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia with Hyperdiploid Complex Karyotype: A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

From Ex-Vivo T-Cell Depletion to Post-Transplant Cyclophosphamide: Improved GvHD-Free & Relapse-Free Survival but Comparable Chronic GvHD Incidence in Haploidentical Transplantation. A 15 Years EBMT Registry Analysis on Behalf of the TCWP-EBMT

The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

The Measurable Residual Disease Status of Acute Myeloid Leukemia in First Complete Remission at Allogeneic Hematopoietic Cell Transplantation Interacts with Conditioning Intensity to Predict Outcome

The Disease Risk Index Is a Robust Tool for Allogeneic Hematopoietic Stem Cell Transplantation Risk Stratification: An Independent Validation Study on a Large Cohort of the European Society for Blood and Marrow Transplantation (EBMT)

Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Pomalidomide, Cyclophosphamide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Retrospective Single Center Experience

Upfront Autologous Stem Cell Transplantation for Newly Diagnosed Elderly Multiple Myeloma (MM) Patients: A Prospective Multicenter Study

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only